KALVISTA PHARMACEUTICALS INC KALV
COM · Common Stock · CUSIP 483497103
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $27.00.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 94 |
| Q4 2022 | 91 |
| Q1 2023 | 90 |
| Q2 2023 | 96 |
| Q3 2023 | 102 |
| Q4 2023 | 94 |
| Q1 2024 | 130 |
| Q2 2024 | 120 |
| Q3 2024 | 123 |
| Q4 2024 | 131 |
| Q1 2025 | 129 |
| Q2 2025 | 141 |
| Q3 2025 | 145 |
| Q4 2025 | 162 |
| Q1 2026 | 184 |
| Q2 2026 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2024 | 65 | 44 |
| Q4 2024 | 69 | 48 |
| Q1 2025 | 67 | 57 |
| Q2 2025 | 83 | 50 |
| Q3 2025 | 80 | 60 |
| Q4 2025 | 86 | 67 |
| Q1 2026 | 98 | 61 |
| Q2 2026 | 1 | 180 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2025 | $14.1m | $10.6m | 0.75 |
| Q4 2025 | $6.4m | $235.8k | 0.04 |
| Q1 2026 | $39.1m | $21.2m | 0.54 |
| Q2 2026 | $0 | $0 | — |
Biggest buyers
| IFP Advisors, Inc | New | +7 |
Biggest sellers
| Venrock Adviser, LLC | Sold out | -6.5m |
| Frazier Life Sciences Management, L.P. | Sold out | -5.0m |
| MONTANOVA CAPITAL, LLC | Sold out | -4.8m |
| TANG CAPITAL MANAGEMENT LLC | Sold out | -4.6m |
| BlackRock, Inc. | Sold out | -3.8m |
| SILVERARC CAPITAL MANAGEMENT, LLC | Sold out | -2.9m |
| Capital World Investors | Sold out | -2.8m |
| Point72 Asset Management, L.P. | Sold out | -2.1m |
| STATE STREET CORP | Sold out | -2.0m |
| MILLENNIUM MANAGEMENT LLC | Sold out | -1.9m |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Capital World Investors 13G · institution filed 2025-05-13 | 6.4% |
| SILVERARC CAPITAL MANAGEMENT, LLC 13G · institution new · filed 2026-05-13 | 5.6% |
Fell to 5% or below in the last year: TANG CAPITAL MANAGEMENT LLC (0.0%, 2026-08-14), GLAZER CAPITAL, LLC (4.8%, 2026-06-10), Frazier Life Sciences Public Fund, L.P. (2.3%, 2026-05-21), Point72 Asset Management, L.P. (4.2%, 2026-05-15), MILLENNIUM MANAGEMENT LLC (3.7%, 2026-05-01), Vestal Point Capital, LP (1.5%, 2025-11-14)
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| IFP Advisors, Inc 0.00% of their portfolio | 7 $189 | New |